Details for Patent: 9,357,783
✉ Email this page to a colleague
Which drugs does patent 9,357,783 protect, and when does it expire?
Patent 9,357,783 protects XEGLYZE and is included in one NDA.
This patent has twenty-six patent family members in fourteen countries.
Summary for Patent: 9,357,783
| Title: | Methods and compositions for controlling ectoparasites |
| Abstract: | A method for inhibiting hatching of an ectoparasite egg, the method comprising exposing the ectoparasite egg to at least one metal chelating agent and/or metalloprotease inhibitor, wherein the metal chelating agent is a compound comprising at least two heteroatoms able to simultaneously coordinate with a metal ion, at least one of the two heteroatoms being selected from nitrogen, sulfur, oxygen and phosphorus, wherein the compound comprises at least one carbocyclic ring substituted with at least one heteroatom and/or with a substituent containing at least one heteroatom, or the compound comprises at least one heterocyclic ring containing at least one heteroatom, wherein said heterocyclic ring is optionally substituted with at least one heteroatom and/or with a substituent containing at least one heteroatom is provided. Methods of treating ectoparasite infestations and compositions for use in such methods are also provided. |
| Inventor(s): | Bowles; Vernon Morrison (Glen Iris, AU) |
| Assignee: | HatchTech Pty Ltd. (Camberwell, Victoria, AU) |
| Application Number: | 13/540,302 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Compound; Delivery; |
Drugs Protected by US Patent 9,357,783
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,357,783
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Australia | 2003903686 | Jul 16, 2003 |
International Family Members for US Patent 9,357,783
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2004257351 | ⤷ Try a Trial | |||
| Australia | 2006207812 | ⤷ Try a Trial | |||
| Brazil | PI0412544 | ⤷ Try a Trial | |||
| Brazil | PI0606577 | ⤷ Try a Trial | |||
| Canada | 2532789 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
